Full Description
This new and thoroughly updated textbook and its companion volume elucidates the etiology of heart failure (HF) to assist understanding of the clinical therapies and surgery available. They explain these in light of the better understanding of the pathophysiology of HF, which has translated into dramatic improvements in patient outcome.
The chapters detail the causes, diagnosis and treatment of HF, recognizing that having become the leading cause of morbidity, mortality and hospitalization in the developed world, even patients with the most advanced HF have options that allow prolonged survival. This includes alternatives to cardiac transplantation, including mechanical circulatory support with a rapidly growing number of new, smaller, more reliable devices becoming available.
Heart Failure II: A Comprehensive Guide to Pathophysiology and Clinical Care remains an important reference for all involved in the management of these patients and provides a scientific and clinical resource for trainees in cardiovascular disease as well as physicians involved in caring for these patients.
Contents
Patient Selection for Cardiac Transplantation.- Pathophysiology of the Alloimmune Response and Immunosuppression.- Antibody-Mediated Rejection.- Infections After Cardiac Transplantation.- Post-transplant Complications: Hypertension, Renal Dysfunction, Diabetes Mellitus, Malignancy, Arrhythmias, Osteoporosis, Sexual Dysfunction.- Biomarkers and Cardiac Transplantation.- Patient Selection for Durable Mechanical Circulatory Support.- Acute Mechanical Circulatory Support.- Mechanical Circulatory Support as a Bridge to Heart Transplantation.- Medical Management of the Patient with Chronic Mechanical Circulatory Support.- The Total Artificial Heart.- Xenotransplantation.- The Role of the Advanced Practice Provider in the Management of Patients with Heart Failure.- Physiology of Stem Cells.- Stem Cell Therapy in Heart Failure.- Gene Therapy for Heart Failure.- Origins of Quality Metrics.- Exercise and Patients with Heart Failure and Reduced Ejection Fraction.- Heart Failure Management and Development of Heart Failure Programs.- Inflammation & heart failure.- Cancer Treatments, Cardiovascular Disease, and Cardiac Tumors.
